相关实验视频
Updated: May 2, 2026

07:36
Angiogenesis in the Ischemic Rat Lung
Published on: February 8, 2013
15.3K
高胆固醇血症抑制血管生成,以应对后肢缺血:依赖氧化的机制
1Cardiovascular Research Institute and Department of Internal Medicine III, Kurume University School of Medicine, Kurume, Japan.
Circulation
|November 18, 2000
概括
高胆固醇在大鼠的四肢缺血后损害了血管形成. 口服L-氨酸补充剂通过提高氧化 (NO) 活性来改善血管生成.
科学领域:
- 心血管生物学 心血管生物学
- 血管生物学 血管生物学
- 再生医学是一种再生医学.
背景情况:
- 内皮衍生的氧化 (EDNO) 调节血管生成.
- 高胆固醇血症 (HC) 会影响EDNO的释放.
- 通过EDNO减小,HC可能会通过EDNO减小抑制血管新生后缺血.
研究的目的:
- 研究HC是否通过减少EDNO来抑制缺血诱导的血管生成.
- 确定L-氨酸补充是否可以预防HC相关的血管生成损伤.
主要方法:
- 鼠被养标准,高胆固醇 (HC) 或HC与L-氨酸饮食.
- 单侧后肢缺血是通过手术诱导的.
- 分析了血液流动,血管造影,毛细血管密度和组织NOx) /cGMP水平.
主要成果:
- HC显著降低了缺血肢体的血液流动,血管生成和毛细血管密度.
- HC与组织氧化 (NO) 生物可用性降低有关.
- 补充L-氨酸显著改善了HC大鼠的血液流动和血管生成.
结论:
- 饮食引起的高胆固醇血症减弱了后肢缺血后的血管生成.
- 减少NO的生物可用性是HC中血管生成受损的可能机制.
- 补充L-氨酸有效地恢复了HC大鼠的血管生成.
相关概念视频
Mechanism of Angiogenesis
6.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.4K
Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Nitric Oxide Signaling Pathway
5.3K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.3K
Cholesterol: Significance and Regulation
2.1K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
2.1K
Angina IV: Management
493
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
493
Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741

